Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
794.99
-12.72 (-1.57%)
Aug 28, 2026, 12:02 PM EDT - Market open
Regeneron Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Hold Maintains $770 | Hold | Maintains | $770 | -3.14% | Aug 20, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $800 | Buy | Maintains | $800 | +0.63% | Aug 18, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $641 → $824 | Hold | Maintains | $641 → $824 | +3.65% | Aug 17, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $750 | Hold | Maintains | $750 | -5.66% | Aug 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $850 → $900 | Buy | Maintains | $850 → $900 | +13.21% | Aug 5, 2026 |
| Barclays | Barclays | Buy Maintains $917 | Buy | Maintains | $917 | +15.35% | Aug 5, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $1,000 → $1,030 | Buy | Maintains | $1,000 → $1,030 | +29.56% | Aug 3, 2026 |
| Citi | Citi | Hold Maintains $700 → $740 | Hold | Maintains | $700 → $740 | -6.92% | Aug 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.